United States · Series A startup

Who invested in Apollon

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$3.8Mraised across 2 rounds since 2025, from 2 sources

$50KGrant$3.7MSeries A
Latest round
Series A, $3.7MSept 2026
Step-upi
74×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026
$50KGrant$3.7MSeries A
First round
Grant, $50K
Nov 2025
Biggest round
$3.7M
Series A · Sept 2026
Between rounds
10 months
from the last two

The rounds

  1. Sept 2026
    Series A$3.7M1 new1 returning

    Source recorded

  2. Nov 2025

Founders and team

From Apollon's own website: 2 founders.

Aram HongCEO & Co-founder
Asan Medical Center ProfessorFounder

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Apollon

Who invested in Apollon?

Apollon's investors include Korea Tech Incubator Program For Startup, SBI Investment and KB Investment.

How much has Apollon raised?

Apollon has raised $3.8M across 2 rounds since 2025.

When did Apollon last raise?

Apollon's most recent round was a Series A of $3.7M in Sept 2026.

What was Apollon's biggest round?

Its most recent round, $3.7M in Sept 2026, is also its largest on record.

Who backed Apollon first?

Apollon's first round on record, in Nov 2025, was backed by Korea Tech Incubator Program For Startup and KB Investment.

What stage is Apollon at?

Apollon's latest named round is a Series A, in Sept 2026.

Where is Apollon based?

Apollon is based in the United States.

Companies like Apollon

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.